StartseitevorwärtsAktienvorwärtsSCHOTT Pharma AktievorwärtsNachrichten zu SCHOTT Pharma

    EQS-PVR

    209 Aufrufe 209 0 Kommentare 0 Kommentare

    SCHOTT Pharma AG & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

    Für Sie zusammengefasst
    • SCHOTT Pharma AG reports voting rights changes.
    • SMALLCAP World Fund holds 2.92% voting rights now.
    • Threshold crossed on 24 Sep 2025, down from 3.31%.
    EQS-PVR - SCHOTT Pharma AG & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
    Foto: Martin Schutt - picture alliance/dpa/dpa-Zentralbild

    EQS Voting Rights Announcement: SCHOTT Pharma AG & Co. KGaA
    SCHOTT Pharma AG & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

    26.09.2025 / 18:40 CET/CEST
    Dissemination of a Voting Rights Announcement transmitted by EQS News - a service of EQS Group.
    The issuer is solely responsible for the content of this announcement.
    Anzeige 
    Handeln Sie Ihre Einschätzung zu SCHOTT Pharma AG!
    Long
    16,80€
    Basispreis
    1,57
    Ask
    × 11,53
    Hebel
    Zum Produkt
    Blatt
    Short
    19,50€
    Basispreis
    1,60
    Ask
    × 11,31
    Hebel
    Zum Produkt
    Blatt
    Präsentiert von

    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.

    Notification of Major Holdings

    1. Details of issuer
    Name: SCHOTT Pharma AG & Co. KGaA
    Street: Hattenbergstraße 10
    Postal code: 55122
    City: Mainz
    Germany
    Legal Entity Identifier (LEI): 529900TU48UE99NHEY88

    2. Reason for notification
    X Acquisition/disposal of shares with voting rights
    X Acquisition/disposal of instruments
      Change of breakdown of voting rights
      Other reason:

    3. Details of person subject to the notification obligation
    Legal entity: SMALLCAP World Fund, Inc.
    City of registered office, country: Lutherville Timonium, United States of America (USA)

    4. Names of shareholder(s)
    holding directly 3% or more voting rights, if different from 3.
     

    5. Date on which threshold was crossed or reached:
    24 Sep 2025
    Seite 1 von 4 


    Diskutieren Sie über die enthaltenen Werte



    Autor
    EQS Group AG
    0 Follower
    Autor folgen
    RSS IconRSS-Feed abonnieren

    Verfasst von EQS Group AG
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    EQS-PVR SCHOTT Pharma AG & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution EQS Voting Rights Announcement: SCHOTT Pharma AG & Co. KGaA SCHOTT Pharma AG & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution 26.09.2025 / 18:40 …